ASCO 2019 | Future treatment options for squamous cell lung cancer

Paul Paik

Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.

Share this video